Position in GH
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$440,488
-$8,892 QoQ
Shares Held
2,936
-39.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#379
of 593 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $248,714,745 across 20 Diagnostics & Research names. GH ranks #15 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
256,270 | $71,755,600 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
83,037 | $41,631,428 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
200,527 | $38,745,826 | |
| 4 | NEO |
Neogenomics Inc
|
1,517,586 | $22,141,578 | |
| 5 | DHR |
Danaher Corp /De/
|
102,849 | $19,590,676 | |
| 6 | WAT |
Waters Corp /De/
|
51,447 | $19,294,681 | |
| 7 | DGX |
Quest Diagnostics Inc
|
84,087 | $17,822,239 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
11,638 | $6,126,707 |
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,488 | 2,936 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $449,380 | 4,865 | Shares | Defined | 2026-05-26 | |
| 2025-12-31 | $495,685 | 4,853 | Shares | Sole | 2026-02-17 | |
| 2020-09-30 | $120,163 | 1,075 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $87,214 | 1,075 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $487,130 | 6,999 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||